The analysis of mucosal immune responses induced by intranasal administration of an inactivated influenza virus vaccine in human (V)

Not Applicable

• Conditions: Influenza

• Registration Number: JPRN-UMIN000015851
• Lead Sponsor: ational Institute of Infectious Diseases

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-12-06
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1. Volunteers with a fever at the time of planned vaccination. 2. Volunteers with serious acute diseases. 3. Volunteers considered inappropriate to be inoculated vaccine.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eutralization, HI, and HA-specific antibody titers before and after intranasal vaccination.

Secondary Outcome Measures

Name	Time	Method
1. Survey on side reaction after vaccination. 2. The proportion of plasma cell in peripheral blood and the repertoire of antibodies induced by vaccination. 3. Cytokine profile after vaccinaton.